本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ProKidney Corp.

1.73
+0.12007.45%
盤後1.69-0.0400-2.31%19:30 EDT
成交量:75.17萬
成交額:127.75萬
市值:5.23億
市盈率:-3.11
高:1.76
開:1.62
低:1.62
收:1.61
52周最高:3.48
52周最低:1.30
股本:3.02億
流通股本:9,327.38萬
量比:0.51
換手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-0.5566
每股收益(LYR):-0.5150
淨資產收益率:-58.96%
總資產收益率:-35.66%
市淨率:-0.59
市盈率(LYR):-3.36

資料載入中...

2025/07/15

重要事件披露

Form 8-K - Current report
2025/07/14

重要事件披露

Form 8-K - Current report
2025/07/08

關聯方擬減持公告

Form 144 | PROKIDNEY高管 Darin J Weber 擬減持103480股,總價約62760.62美元
2025/07/08

重要事件披露

Form 8-K - Current report
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/03

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

重要事件披露

Form 8-K - Current report
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/25

SEC問詢函

Form CORRESP - Correspondence
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/17

重要事件披露

Form 8-K - Current report
2025/01/22

重要事件披露

Form 8-K - Current report
2024/11/22

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report